Submission based on DESTINY-Lung02 and DESTINY-Lung01 phase 2 trial results which showed Daiichi Sankyo and AstraZeneca’s ENHERTU demonstrated a clinically meaningful tumor response
TOKYO & MUNICH--(BUSINESS WIRE)--Daiichi Sankyo…
NAPLES, Fla., Dec. 01, 2022 (GLOBE NEWSWIRE) -- For demonstrating technical proficiency and proven client success, Intetics, a leading global technology company, achieved the AWS Service Delivery designation for Amazon Elastic Compute…
Image available: monika@prismapr.com Caption: Available in a range of screen sizes and featuring Intel® Core™ i3 or i7 processors, the Navis Ready JLT VERSO computers are validated to run the most demanding port…